Many athletes with asthma may be using the wrong treatment – EurekAlert (press release)

Many athletes with asthma may be using the wrong treatment
EurekAlert (press release)
Many athletes with asthma may not be using the best treatment for their condition and could be putting their long term health at risk, according to a roundup by journalist Sophie Arie published by the BMJ today. The article will feature on the BMJ's

and more »

View full post on asthma – Google News

Developer of New Treatment for Severe Asthma Episodes Expects Phase 2 Clinical … – Benzinga

Developer of New Treatment for Severe Asthma Episodes Expects Phase 2 Clinical
Benzinga
the Founder, President and Chief Executive Officer of MediciNova, Inc. (NASDAQ: MNOV) tells investors about a promising treatment approach aimed at meeting the need for novel treatments for patients suffering from acute exacerbations of asthma,

and more »

View full post on asthma – Google News

Positive Results in Trial for New Asthma Treatment – news Stories


Daily Mail

Positive Results in Trial for New Asthma Treatment
news Stories
Synairgen, a drug development company that spun out of the University of Southampton, United Kingdom, has announced positive results of a phase 2 clinical trial of its asthma drug SNG001. The trial investigated the potential for SNG001 to protect
Positive SNG001 Phase II Asthma Clinical Trial DataScience 2.0 (press release)
Asthma drug 'protects sufferers from life-threatening symptoms caused by Daily Mail
Synairgen's 'breakthrough' asthma drug shines in Phase II trialPharma Times
The Press Association –Huffington Post UK
all 31 news articles »

View full post on asthma – Google News

Developer of New Treatment for Severe Asthma Episodes Expects Phase 2 Clinical … – MarketWatch (press release)

Developer of New Treatment for Severe Asthma Episodes Expects Phase 2 Clinical
MarketWatch (press release)
aimed at meeting the need for novel treatments for patients suffering from acute exacerbations of asthma (AEA), a long-lasting and severe form of asthma episode in which symptoms are unresponsive to initial bronchodilator or corticosteroid therapy.

and more »

View full post on asthma – Google News

Positive results trial for new asthma treatment – Medical Xpress

Positive results trial for new asthma treatment
Medical Xpress
This pioneering trial investigated the potential for SNG001 to protect asthmatics from respiratory virus infections, principally the common cold, that can spread to the lung, which are a major cause of worsening asthma symptoms.
Synairgen reports positive Phase II asthma trial dataPharmaceutical Business Review
Synairgen no wheeze as asthma drug trial boosts sharesShareCast

all 14 news articles »

View full post on asthma – Google News

Positive results in Southampton-led patient trial for new asthma treatment – Science Codex

Positive results in Southampton-led patient trial for new asthma treatment
Science Codex
This pioneering trial investigated the potential for SNG001 to protect asthmatics from respiratory virus infections, principally the common cold, that can spread to the lung, which are a major cause of worsening asthma symptoms.
Synairgen reports positive Phase II asthma trial dataPharmaceutical Business Review
Synairgen no wheeze as asthma drug trial boosts sharesShareCast

all 13 news articles »

View full post on asthma – Google News